• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名有肺叶切除病史患者的低剂量胺碘酮所致肺毒性

Low dose amiodarone pulmonary toxicity in a patient with a history of pneumonectomy.

作者信息

van der Zeyden H, Zandstra D, van Hengstum M

机构信息

Andreas Hospital, Amsterdam, The Netherlands.

出版信息

Intensive Care Med. 1992;18(7):422-3. doi: 10.1007/BF01694345.

DOI:10.1007/BF01694345
PMID:1469181
Abstract

A case of amiodarone pulmonary toxicity (APT) is described following a low dosage of amiodarone (200 mg/day) with serious respiratory insufficiency in a patient after right pneumonectomy. The patient was successfully treated by discontinuation of amiodarone, mechanical ventilation and prednisolone (40 mg/day). A literature study indicates that APT is a dose related toxicity. In our opinion a higher pulmonary drug concentration of amiodarone could exist from a change in pharmacokinetics because of a low fat storage in a thin patient and compensatory growth of the remaining lung which occurs after pneumonectomy. Given these findings we suggest that if amiodarone is indicated in such patients both loading and maintenance doses should be adapted.

摘要

本文描述了一例右肺切除术后患者在服用低剂量胺碘酮(200mg/天)后出现胺碘酮肺毒性(APT)并伴有严重呼吸功能不全的病例。通过停用胺碘酮、机械通气和使用泼尼松龙(40mg/天),该患者得到了成功治疗。一项文献研究表明,APT是一种与剂量相关的毒性。我们认为,由于瘦患者脂肪储存量低以及肺切除术后剩余肺组织的代偿性生长,药代动力学发生改变,可能导致胺碘酮在肺部的药物浓度升高。基于这些发现,我们建议,如果在此类患者中需要使用胺碘酮,负荷剂量和维持剂量均应进行调整。

相似文献

1
Low dose amiodarone pulmonary toxicity in a patient with a history of pneumonectomy.一名有肺叶切除病史患者的低剂量胺碘酮所致肺毒性
Intensive Care Med. 1992;18(7):422-3. doi: 10.1007/BF01694345.
2
[Respiratory insufficiency due to pulmonary toxicity of amiodarone].[胺碘酮肺毒性所致呼吸功能不全]
Ned Tijdschr Geneeskd. 1995 Jul 22;139(29):1501-4.
3
[Amiodarone induced pulmonary toxicity].[胺碘酮诱发的肺毒性]
Pneumologie. 2002 Jan;56(1):31-5. doi: 10.1055/s-2002-19567.
4
The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.胸部计算机断层扫描评分在评估胺碘酮所致肺毒性中的诊断效用。
Korean J Intern Med. 2014 Nov;29(6):746-53. doi: 10.3904/kjim.2014.29.6.746. Epub 2014 Oct 31.
5
[Amiodarone-induced pulmonary fibrosis].
Orv Hetil. 1996 Aug 11;137(32):1759-62.
6
[Steroid-refractory amiodarone-induced pulmonary fibrosis. Clinical features and morphology after an amiodarone-free interval of 3 months].[类固醇难治性胺碘酮所致肺纤维化。在停用胺碘酮3个月后的临床特征及形态学表现]
Dtsch Med Wochenschr. 1988 Oct 21;113(42):1638-41. doi: 10.1055/s-2008-1067863.
7
Amiodarone and pulmonary fibrosis.胺碘酮与肺纤维化。
Eur J Clin Pharmacol. 1983;24(5):591-3. doi: 10.1007/BF00542206.
8
Pneumonectomy for unilateral lung disease associated with respiratory failure.针对与呼吸衰竭相关的单侧肺部疾病进行肺切除术。
Am Rev Respir Dis. 1973 Sep;108(3):652-5. doi: 10.1164/arrd.1973.108.3.652.
9
Fibrosing alveolitis associated with amiodarone.与胺碘酮相关的纤维化肺泡炎。
Eur J Respir Dis. 1984 Nov;65(8):616-9.
10
Amiodarone pulmonary toxicity.胺碘酮肺毒性。
Am Heart J. 1983 Oct;106(4 Pt 2):906-16. doi: 10.1016/0002-8703(83)90015-7.

引用本文的文献

1
Amiodarone-induced pulmonary toxicity. Predisposing factors, clinical symptoms and treatment.胺碘酮所致肺毒性。易感因素、临床症状及治疗。
Drug Saf. 1998 May;18(5):339-44. doi: 10.2165/00002018-199818050-00003.

本文引用的文献

1
Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.胺碘酮治疗相关的肺炎和肺纤维化:一种新型抗心律失常药物可能的并发症。
Circulation. 1982 Apr;65(4):819-24. doi: 10.1161/01.cir.65.4.819.
2
Pulmonary gallium-67 uptake in amiodarone pneumonitis.
J Nucl Med. 1984 Feb;25(2):211-3.
3
Amiodarone pulmonary toxicity: prospective evaluation of serial pulmonary function tests.胺碘酮肺毒性:连续肺功能测试的前瞻性评估
J Am Coll Cardiol. 1988 Sep;12(3):781-8. doi: 10.1016/0735-1097(88)90321-x.
4
Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).胺碘酮肺毒性。认识与发病机制(第一部分)。
Chest. 1988 May;93(5):1067-75. doi: 10.1378/chest.93.5.1067.
5
Postpneumonectomy compensatory lung growth.肺切除术后代偿性肺生长
Am Rev Respir Dis. 1988 Nov;138(5):1314-26. doi: 10.1164/ajrccm/138.5.1314.
6
[Pneumonitis following amiodarone therapy].[胺碘酮治疗后肺炎]
J Belge Radiol. 1989 Apr;72(2):107-9.
7
Pulmonary accumulation of amiodarone and N-desethylamiodarone. Relationship to the development of pulmonary toxicity.
Am Rev Respir Dis. 1990 Jun;141(6):1553-8. doi: 10.1164/ajrccm/141.6.1553.
8
Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity.胺碘酮肝毒性和肺毒性与血清药物浓度及超氧化物歧化酶活性的关系。
Am J Cardiol. 1990 May 15;65(18):1185-91. doi: 10.1016/0002-9149(90)90971-3.
9
Mechanisms of amiodarone pulmonary toxicity.胺碘酮肺毒性的机制。
Clin Chest Med. 1990 Mar;11(1):131-8.